Marine pseudovibrio sp. as a novel source of antimicrobials

Marine Drugs

Volumn 12, Issue 12, 2014, Pages 5916-5929

  Crowley, Susan P ^a,b   O'Gara, Fergal ^b   O'Sullivan, Orla ^a,c   Cotter, Paul D ^a,c   Dobson, Alan D W ^b,d  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d Environmental Research Institute   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BIOLOGICAL PRODUCT; HEPTYLPRODIGIOSIN; TROPODITHIETIC ACID; UNCLASSIFIED DRUG;

ANTIBIOTIC BIOSYNTHESIS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM EXAMINATION; BACTERIUM ISOLATE; BIOLOGICAL ACTIVITY; DRUG DETERMINATION; DRUG POTENCY; DRUG STRUCTURE; MARINE SPECIES; NONHUMAN; NRPS GENE; PKS GENE; PSEUDOVIBRIO; PSEUDOVIBRIO ASCIDIACEICOLA; PSEUDOVIBRIO AXINELLAE; PSEUDOVIBRIO DENITRIFICANS; PSEUDOVIBRIO JAPONICAS; REVIEW; RHODOBACTERACEAE; ANIMAL; BACTERIUM; CHEMISTRY; MARINE BIOLOGY; PROCEDURES;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIA; BIOLOGICAL PRODUCTS; MARINE BIOLOGY; RHODOBACTERACEAE;

EID: 84919884417     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md12125916     Document Type: Review

References (48)

1. United State Department of Health and Human Services. Antibiotic Resistance Threats in the Unites States; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2013.
2. ECDC. Annual Epidemiological Report 2012; European Center for Disease Prevention and Control: Tomtebodavägen 11a, 17183, Stockholm, Sweden. Available Online: http://www.ecdc.europa.eu/en/publications/Annual-Epidemiological-Report-2012.pdf (accessed on 14 February 2014).
3. Kanerva, M.; Ollgren, J.; Hakanen, A.J.; Lyytikäinen, O. Estimating the burden of healthcare-associated infections caused by selected multidrug-resistant bacteria Finland, 2010. Antimicrob. Resist. Infect. Control 2012, 1, doi:10.1186/2047-2994-1-33.
4. Infectious Diseases Society of America. The 10 × '20 initiative: Pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin. Infect. Dis. 2010, 50, 1081-1083.
5. Talbot, G.H.; Bradley, J.; Edwards, J.E.; Gilbert, D.; Scheld, M.; Bartlett, J.G. Bad bugs need drugs: An update on the development pipeline from the antimicrobial availability task force of the infectious diseases society of America. Clin. Infect. Dis. 2006, 42, 657-668.
6. Penesyan, A.; Kjelleberg, S.; Egan, S. Development of novel drugs from marine surface associated microorganisms. Mar. Drugs 2010, 8, 438-459.
7. Penesyan, A.; Marshall-Jones, Z.; Holmstrom, C.; Kjelleberg, S.; Egan, S. Antimicrobial activity observed among cultured marine epiphytic bacteria refects their potential as a source of newdrugs. Fed. Eur. Microbiol. Soc. 2009, 69, 113-124.
8. European Science Foundation. A New Vision and Strategy for Europe; Marine Board: Ostend, Belgium, 2012.
9. Lam, K.S. Discovery of novel metabolites from marine actinomycetes. Curr. Opin. Microbiol. 2006, 9, 245-251.
10. Prudhomme, J.; McDaniel, E.; Ponts, N.; Bertani, S.; Fenical, W.; Jensen, P.; le Roch, K. Marine actinomycetes: A new source of compounds against the human malaria parasite. PLoS One 2008, doi:10.1371/journal.pone.0002335.
11. Hentschel, U.; Schmid, M.; Wagner, M.; Fieseler, L.; Gernert, C.; Hacker, J. Isolation and phylogenetic analysis of bacteria with antimicrobial activities from the Mediterranean sponges Aplysina aerophoba and Aplysina cavernicola. FEMS Microbiol. Ecol. 2001, 35, 305-312.
12. Viegelmann, C.; Margassery, L.; Kennedy, J.; Zhang, T.; OBrien, C.; O'Gara, F.; Morrisssey, J.; Dobson, A.; Edrada-Ebel, R. Metabolomic profiling and genomic study of a marine sponge-associated Streptomyces sp. Mar. Drugs 2014, 12, 3323-3351.
13. Prieto, M.L.; O'Sullivan, L.; Tan, S.P.; McLoughlin, P.; Hughes, H.; O'Connor, P.M.; Cotter, P.D.; Lawlor, P.G.; Gardiner, G.E. Assessment of the bacteriocinogenic potential of marine bacteria reveals lichenicidin production by seaweed-derived Bacillus spp. Mar. Drugs 2012, 10, 2280-2299.
14. Desriac, F.; Jégou, C.; Balnois, E.; Brillet, B.; le Chevalier, P.; Fleury, Y. Antimicrobial peptides from marine proteobacteria. Mar. Drugs 2013, 11, 3632-3660.
15. Sertan-de Guzman, A.A.; Bernardo, R.Z.; Neilan, B.A.; Elardo, S.P.; Mangalindan, G.C.; Tasdemir, D.; Ireland, C.M.; Barraquio, W.L.; Concepcion, G.P. Pseudovibrio denitrificans strain Z143-1, a heptylprodigiosin-producing bacterium isolated from a Philippine tunicate. FEMS Microbiol. Lett. 2007, 277, 188-196.
16. Geng, H.F.; Belas, R. Expression of tropodithietic acid biosynthesis is controlled by a novel autoinducer. J. Bacteriol. 2010, 192, 4377-4387.
17. Thiel, V.; Imhoff, J.F. Phylogenetic identification of bacteria with antimicrobial activities isolated from Mediterranean sponges. Biomol. Eng. 2003, 20, 421-423.
18. Muscholl-Silberhorn, A.; Thiel, V.; Imhoff, J.F. Abundance and bioactivity of cultured sponge-associated bacteria from the mediterranean sea. Microb. Ecol. 2008, 55, 94-106.
19. Kennedy, J.; Baker, P.; Piper, C.; Cotter, P.D.; Walsh, M.; Mooij, M.J.; Bourke, M.B.; Rea, M.C.; O'Connor, P.M.; Ross, R.P.; et al. Isolation and analysis of bacteria with antimicrobial activities from the marine sponge Haliclona simulans collected from Irish waters. Mar. Biotechnol. 2009, 11, 384-396.
20. Fukunaga, Y.; Kurahashi, M.; Tanaka, K.; Yanavfbgi, K.; Yokota, A.; Harayama, S. Pseudovibrio ascidiaceicola sp. nov., isolated from ascidians (sea squirts). Int. J. Syst. Evol. Microbiol. 2006 , 56, 343 347.
21. Vizcaino, M.; Moeller, P.; Morris, P. The Potential for the Marine Bacterium Pseudovibrio denitrificans to Produce Novel Antibiotics. Available Online: https://www.musc.edu/mbes-ljg/ MBESOpenHouse/2010/abstracts/Vizcaino-SROH-July-16-2010.pdf (accessed on 30 March 2014).
22. Shieh, W.Y.; Lin, Y.T.; Jean, W.D. Pseudovibrio denitrificans gen. nov., sp. nov., a marine, facultatively anaerobic, fermentative bacterium capable of denitrification. Int. J. Syst. Evol. Microbiol. 2004, 54, 2307-2312.
23. Penesyan, A.; Tebben, J.; Lee, M.; Thomas, T.; Kjelleberg, S.; Harder, T.; Egan, S. Identification of the antibacterial compound produced by the marine epiphytic bacterium Pseudovibrio sp. D323 and related sponge-associated bacteria. Mar. Drugs 2011, 9, 1391-1402.
24. Enticknap, J.J.; Kelly, M.; Peraud, O.; Hill, R. Characterization of a culturable alphaproteobacterial symbiont common to many marine sponges and evidence for vertical transmission via sponge larvae. Appl. Environ. Microbiol. 2006, 72, 3724-3732.
25. Graca, A.P.; Bondoso, J.; Gaspar, H.; Xavier, J.R.; Monteiro, M.C.; de la Cruz, M.; Oves-Costales, D.; Vicente, F.; Lage, O.M. Antimicrobial Activity of Heterotrophic Bacterial Communities from the Marine Sponge Erylus discophorus (Astrophorida, Geodiidae). PLoS One 2013, 8, e78992.
26. Taylor, M.; Radax, R.; Seger, D.; Wagner, M. Sponge-associated microorganisms: Evolution, ecology, and biotechnological potential. Microbiol. Mol. Biol. Rev. 2007, 71, 295-347.
27. Esteves, A.I.; Hardoim, C.C.; Xavier, J.R.; Goncalves, J.M.; Costa, R. Molecular richness and biotechnological potential of bacteria cultured from Irciniidae sponges in the north-east Atlantic. FEMS Microbiol. Ecol. 2013, 85, 519-536.
28. Santos, O.C.; Pontes, P.V.; Santos, J.F.; Muricy, G.; Giambiagi-deMarval, M.; Laport, M.S. Isolation, characterization and phylogeny of sponge-associated bacteria with antimicrobial activities from Brazil . Res. Microbiol. 2010, 161, 604-612.
29. Margassery, L.M.; Kennedy, J.; O'Gara, F.; Dobson, A.D.; Morrissey, J.P. Diversity and antibacterial activity of bacteria isolated from the coastal marine sponges Amphilectus fucorum and Eurypon major. Lett. Appl. Microbiol. 2012, 55, 2-8.
30. Hosoya, S.; Yokota, A. Pseudovibrio japonicus sp. nov., isolated from coastal seawater in Japan. Int. J. Syst. Evol. Microbiol. 2007, 57, 1952-1955.
31. O'Halloran, J.A.; Barbosa, T.M.; Morrissey, J.P.; Kennedy, J.; Dobson, A.D.; O'Gara, F. Pseudovibrio axinellae sp. nov., isolated from an Irish marine sponge. Int. J. Syst. Evol. Microbiol. 2013, 63, 141-145.
32. Kennedy, J.; Codling, C.E.; Jones, B.V.; Dobson, A.D.; Marchesi, J.R. Diversity of microbes associated with the marine sponge, Haliclona simulans, isolated from Irish waters and identification of polyketide synthase genes from the sponge metagenome. Environ. Microbiol. 2008, 10, 1888-1902.
33. O'Halloran, J.A.; Barbosa, T.M.; Morrissey, J.P.; Kennedy, J.; O'Gara, F.; Dobson, A.D. Diversity and antimicrobial activity of Pseudovibrio spp. from Irish marine sponges. J. Appl. Microbiol. 2011. 110, 1495-1508.
34. Flemer, B.; Kennedy, J.; Margassery, L.M.; Morrissey, J.P.; O'Gara, F.; Dobson, A.D. Diversity and antimicrobial activities of microbes from two Irish marine sponges, Suberites carnosus and Leucosolenia sp. J. Appl. Microbiol. 2011, 112, 289-301.
35. Bruhn, J.B.; Gram, L.; Belas, R. Production of antibacterial compounds and biofilm formation by Roseobacter species are influenced by culture conditions. Appl. Environ. Microbiol. 2007, 73, 442-450.
36. Fernández-Gómez, B.; Fernàndez-Guerra, A.; Casamayor, E.O.; González, J. M.; Pedrós-Alió, C.; Acinas, S.G. Patterns and architecture of genomic islands in marine bacteria. BMC Genomics 2012, 13, doi:10.1186/1471-2164-13-347.
37. Zhao, X.Q. Genome-based studies of marine of microorganisms to maximize the diversity of natural products discovery for medical treatments. Evid.-Based Complement. Altern. Med. 2011, 2011, doi:10.1155/2011/384572.
38. Bondarev, V.; Rcchter, M.; Romano, S.; Piel, J.; Schwedt, A.; Schulz-Vogt, H.N. The genus Pseudovibrio contains metabolically versatile bacteria adapted for symbiosis. Environ. Microbiol. 2013, 15, 2095-2113.
39. CambridgeSoft Corporation, ChemBioDraw Software. 2012. PerkinElmer, 100 Cambridge Park Drive, Cambridge, MA 02140. Available online: http://www.cambridgesoft.com/ Ensemble-for-Biology/ChemBioDraw/Default.aspx. Analysis and visualisation of molecular structures (Accessed on 23 November 2014).
40. Berger, M.; Neumann, A.; Schulz, S.; Simon, M.; Brinkhoff, T. Tropodithietic acid production in Phaeobacter gallaeciensis is regulated by N-acyl homoserine lactone-mediated quorum sensing. J. Bacteriol. 2011, 193, 6576-6585.
41. Crowley, S.P.; O'Gara, F.; O'Sullivan, O.; Dobson, A.D.W.; Cotter, P.C. Pseudovibrio isolates with anti-Salmonella activity. In progress.
42. Geng, H.; Bruhn, J.B.; Nielsen, K.F.; Gram, L.; Belas, R. Genetic dissection of tropodithietic acid biosynthesis by marine roseobacters. Appl. Environ. Microbiol. 2008, 74, 1535-1545.
43. Putze, J.; Hennequin, C.; Nougayrede, J.P.; Zhang, W.L.; Homburg, S.; Karch, H.; Bringer, M.A.; Fayolle, C.; Carniel, E.; Rabsch, W.; et al. Genetic structure and distribution of the colibactin genomic island among members of the family enterobacteriaceae. Infect. Immun. 2009, 77, 4696-4703.
44. Nougayrède, J.P.; Homburg, S.; Taieb, F.; Boury, M.; Brzuszkiewicz, E.; Gottschalk, G.; Buchrieser, C.; Hacker, J.; Dobrindt, U.; Oswald, E. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 2006, 313, 848-851.
45. Romano, S.; Dittmar, T.; Bondarev, V.; Weber, R.J.M.; Viant, M.R.; Schulz-Vogt, H.N. Exo-Metabolome of Pseudovibrio sp. FO-BEG1 Analyzed by Ultra-High Resolution Mass Spectrometry and the Effect of Phosphate Limitation. PLoS One 2014, 9, e96038.
46. Genomes. Metabolic pathways-Pseudovibrio sp. FO-BEG1. Available online: http://www.genome.jp/kegg-bin/show-pathway?psf01100 (accessed on 20 August 2014).
47. Blin, K.; Medema, M.H.; Kazempour, D.; Fischbach, M.A.; Breitling, R.;Takano, E.; Weber, T. AntiSMASH 2.0-A versatile platform for genome mining of secondary metabolite producers. Nucleic Acids Res. 2013, 41, 204-212.
48. De Jong, A.; van Hijum, S.A.F.T.; Bijlsma, J.J.E.; Kok, J.; Kuipers, O.P. BAGEL: A web-based bacteriocin genome mining tool. Nucleic Acids Res. 2006, 34, 273-279.